# Clinical Trial to Demonstrate That the Dual Laser Therapy is Effective for the Treatment of Vulvar Lichen Sclerosus

> **NCT03926299** · NA · COMPLETED · sponsor: **Prof. Dr. Volker Viereck** · enrollment: 66 (actual)

## Conditions studied

- Chronic Skin Disease
- Vulvar Lichen Sclerosus

## Interventions

- **DEVICE:** FotonaSmooth SP® Spectro laser device
- **DRUG:** Clobetasol propionate 0.05% ointment

## Key facts

- **NCT ID:** NCT03926299
- **Lead sponsor:** Prof. Dr. Volker Viereck
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-15
- **Primary completion:** 2024-07-30
- **Final completion:** 2024-07-30
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03926299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03926299, "Clinical Trial to Demonstrate That the Dual Laser Therapy is Effective for the Treatment of Vulvar Lichen Sclerosus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03926299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*